In silico drug discovery of Acetylcholinesterase and Butyrylcholinesterase enzymes inhibitors based on Quantitative Structure-Activity Relationship (QSAR) and drug …

W Sobhi, A Attoui, T Lemaoui, A Erto… - Journal of Molecular …, 2021 - Elsevier
In the last years, in order to achieve a better treatment of Alzheimer's disease (AD), much
focus has been put on the development of cholinesterase (Acetylcholinesterase and …
被引用次数：36 相关文章

In silico drug discovery of Acetylcholinesterase and Butyrylcholinesterase enzymes inhibitors based on Quantitative Structure-Activity Relationship (QSAR) and drug …

NEH Hammoudi, W Sobhi, A Attoui, T Lemaoui… - JOURNAL OF …, 2021 - iris.unina.it
In the last years, in order to achieve a better treatment of Alzheimer's disease (AD), much
focus has been put on the development of cholinesterase (Acetylcholinesterase and …

In silico drug discovery of Acetylcholinesterase and Butyrylcholinesterase enzymes inhibitors based on Quantitative Structure-Activity Relationship (QSAR) and drug …

NEH Hammoudi, W Sobhi, A Attoui… - Journal of …, 2021 - ui.adsabs.harvard.edu
In the last years, in order to achieve a better treatment of Alzheimer's disease (AD), much
focus has been put on the development of cholinesterase (Acetylcholinesterase and …